Cargando…
An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas
BACKGROUND: Endometrial adenocarcinomas are a rare type of tumour in cats. Though different morphologies have been reported, the most frequent histological type of feline endometrial adenocarcinoma (FEA) is the papillary serous. Characterization of molecular markers expression in FEA may contribute...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535787/ https://www.ncbi.nlm.nih.gov/pubmed/26268561 http://dx.doi.org/10.1186/s12917-015-0530-6 |
_version_ | 1782385652032077824 |
---|---|
author | Saraiva, Ana Laura Payan-Carreira, Rita Gärtner, Fátima Fortuna da Cunha, Marta R. Rêma, Alexandra Faria, Fátima Lourenço, Lígia M. Pires, Maria dos Anjos |
author_facet | Saraiva, Ana Laura Payan-Carreira, Rita Gärtner, Fátima Fortuna da Cunha, Marta R. Rêma, Alexandra Faria, Fátima Lourenço, Lígia M. Pires, Maria dos Anjos |
author_sort | Saraiva, Ana Laura |
collection | PubMed |
description | BACKGROUND: Endometrial adenocarcinomas are a rare type of tumour in cats. Though different morphologies have been reported, the most frequent histological type of feline endometrial adenocarcinoma (FEA) is the papillary serous. Characterization of molecular markers expression in FEA may contribute to clarify the pathogenesis of these tumours and to assess the differences between normal endometrium and FEA regarding the expression pattern of several proteins. Therefore, this study aimed to evaluate the immunohistochemical profile of a wide panel of antibodies (specific for ER-α, PR, Ki-67, CK7 and CK20) in twenty-four cases of FEA. Comparisons were made between FEA and feline normal cyclic endometrium in follicular (n = 13) and luteal (n = 10) stages. Except for Ki-67, all other molecular markers were assessed independently for the intensity of immunolabeling and for the percentage of cells expressing the protein. RESULTS: This study showed that in FEA a loss of expression occurs for ER-α (P ≤ 0.0001) and less markedly also for PR. The lost in sex steroid receptors concerns a decrease in both the proportion of labelled cells and the intensity of immunolabelling (P = 0.002 and P = 0.024, respectively). Proliferative activity, estimated via Ki-67 immunoreaction, significantly increased in FEA as compared to normal endometrium (P ≤ 0.0001). Feline endometrial adenocarcinomas maintained the CK7+/CK20+ status of normal endometrium. However, FEA showed decreased CK7 intensity of labelling compared to normal endometria (P ≤ 0.0001) and loss of CK20 expression, both in intensity (P ≤ 0.0001) and in percentage of positive cells (P = 0.01), compared to normal tissues. CONCLUSIONS: Data gathered in this study suggest that proliferation in FEA accompanies ER-α down-regulation, possibly following activation of pathways mediated by local growth factors. Moreover, FEA retains combined expression of CK7 and CK20, as evidenced in normal endometrial epithelia, although a decrease in CK7 expression was observed. |
format | Online Article Text |
id | pubmed-4535787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45357872015-08-14 An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas Saraiva, Ana Laura Payan-Carreira, Rita Gärtner, Fátima Fortuna da Cunha, Marta R. Rêma, Alexandra Faria, Fátima Lourenço, Lígia M. Pires, Maria dos Anjos BMC Vet Res Research Article BACKGROUND: Endometrial adenocarcinomas are a rare type of tumour in cats. Though different morphologies have been reported, the most frequent histological type of feline endometrial adenocarcinoma (FEA) is the papillary serous. Characterization of molecular markers expression in FEA may contribute to clarify the pathogenesis of these tumours and to assess the differences between normal endometrium and FEA regarding the expression pattern of several proteins. Therefore, this study aimed to evaluate the immunohistochemical profile of a wide panel of antibodies (specific for ER-α, PR, Ki-67, CK7 and CK20) in twenty-four cases of FEA. Comparisons were made between FEA and feline normal cyclic endometrium in follicular (n = 13) and luteal (n = 10) stages. Except for Ki-67, all other molecular markers were assessed independently for the intensity of immunolabeling and for the percentage of cells expressing the protein. RESULTS: This study showed that in FEA a loss of expression occurs for ER-α (P ≤ 0.0001) and less markedly also for PR. The lost in sex steroid receptors concerns a decrease in both the proportion of labelled cells and the intensity of immunolabelling (P = 0.002 and P = 0.024, respectively). Proliferative activity, estimated via Ki-67 immunoreaction, significantly increased in FEA as compared to normal endometrium (P ≤ 0.0001). Feline endometrial adenocarcinomas maintained the CK7+/CK20+ status of normal endometrium. However, FEA showed decreased CK7 intensity of labelling compared to normal endometria (P ≤ 0.0001) and loss of CK20 expression, both in intensity (P ≤ 0.0001) and in percentage of positive cells (P = 0.01), compared to normal tissues. CONCLUSIONS: Data gathered in this study suggest that proliferation in FEA accompanies ER-α down-regulation, possibly following activation of pathways mediated by local growth factors. Moreover, FEA retains combined expression of CK7 and CK20, as evidenced in normal endometrial epithelia, although a decrease in CK7 expression was observed. BioMed Central 2015-08-14 /pmc/articles/PMC4535787/ /pubmed/26268561 http://dx.doi.org/10.1186/s12917-015-0530-6 Text en © Saraiva et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Saraiva, Ana Laura Payan-Carreira, Rita Gärtner, Fátima Fortuna da Cunha, Marta R. Rêma, Alexandra Faria, Fátima Lourenço, Lígia M. Pires, Maria dos Anjos An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas |
title | An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas |
title_full | An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas |
title_fullStr | An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas |
title_full_unstemmed | An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas |
title_short | An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas |
title_sort | immunohistochemical study on the expression of sex steroid receptors, ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535787/ https://www.ncbi.nlm.nih.gov/pubmed/26268561 http://dx.doi.org/10.1186/s12917-015-0530-6 |
work_keys_str_mv | AT saraivaanalaura animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT payancarreirarita animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT gartnerfatima animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT fortunadacunhamartar animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT remaalexandra animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT fariafatima animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT lourencoligiam animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT piresmariadosanjos animmunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT saraivaanalaura immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT payancarreirarita immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT gartnerfatima immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT fortunadacunhamartar immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT remaalexandra immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT fariafatima immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT lourencoligiam immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas AT piresmariadosanjos immunohistochemicalstudyontheexpressionofsexsteroidreceptorski67andcytokeratins7and20infelineendometrialadenocarcinomas |